Celldex Therapeutics
CLDX
#4614
Rank
$2.11 B
Marketcap
$31.72
Share price
7.60%
Change (1 day)
74.77%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of December 2025 : $2.33 Million USD

According to Celldex Therapeutics's latest financial reports the company's total debt is $2.33 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31$2.33 M-38.74%
2024-12-31$3.81 M50%
2023-12-31$2.54 M-36.97%
2022-12-31$4.03 M32.58%
2021-12-31$3.04 M-12.61%
2020-12-31$3.48 M-4.81%
2019-12-31$3.65 M
2018-12-31N/A-100%
2017-12-31$6.56 M
2015-12-31$4.41 M70.45%
2014-12-31$2.59 M
2013-12-31N/A-100%
2012-12-31$11.33 M-25.13%
2011-12-31$15.14 M39.99%
2010-12-31$10.81 M-21.84%
2009-12-31$13.84 M6248.62%
2008-12-31$0.21 M-95.78%
2007-12-31$5.16 M11.32%
2006-12-31$4.64 M122.41%
2005-12-31$2.08 M1019.25%
2004-12-31$0.18 M
2000-12-31$0.27 M-51.23%
1999-12-31$0.56 M-64.82%
1998-12-31$1.6 M0%
1997-12-31$1.6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
$63.96 B 2,737,956.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.60 B 2,337,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$23.86 B 1,021,471.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
$0.11 B 4,758.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$45.77 M 1,859.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 28,286.13%๐Ÿ‡บ๐Ÿ‡ธ USA